pycnogenol
Commercial- Indications
- Asthma, Cardiovascular disease, Joint disorders, Skin conditions, Cognitive disorders
Company intelligence / Profile preview
Horphag Research
Cointrin, Geneva, Switzerlandpycnogenol.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Horphag Research’s flagship ingredient Pycnogenol® has been the subject of over 130–160 clinical trials involving more than ten thousand patients. Clinical results confirm its safety, non-toxicity, and efficacy for cardiovascular support, skin and eye health, joint mobility, cognitive function, energy/vitality enhancement and more. Robuvit®, their French oak wood extract product for energy and sports performance applications, has also won industry awards for innovation.
- Therapeutic areas
- Metabolic DisordersDermatologyRheumatologyCardiovascularOphthalmologyNeurology
- Modalities
- Small moleculePlant extractNatural product
- Industry
- Food & Nutrition
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Hundreds of global supplement/nutraceutical companies license or use their ingredients in finished products
Beyond the preview
Go deeper on Horphag Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Horphag Research.